Skip to main
We’re doing some system maintenance
  1. Home
  2. Stocks
  3. Fortress Biotech Inc 9.375 % Cum Conv Perp Red Pfd Registered Shs Series A
FBIOP

Buy FBIOP Stock

FBIOP
See FBIOP stock price and Buy/Sell Fortress Biotech Inc 9.375 % Cum Conv Perp Red Pfd Registered Shs Series A with any amount of money. Discuss news and analyst's price prediction with the investor community. Enter your cell phone number to get started.
FBIOP

Fortress Biotech Inc 9.375 % Cum Conv Perp Red Pfd Registered Shs Series A (FBIOP)

We couldn’t load this chart.

Some stock charts might currently not be supported. To try again, please refresh this page.

About Fortress Biotech Inc 9.375 % Cum Conv Perp Red Pfd Registered Shs Series A (FBIOP)

Fortress Biotech, Inc. engages in the manufacture and commercialization of novel pharmaceutical products and product candidates. It operates through the Dermatology Product Sales and Pharmaceutical and Biotechnology Product Development segments. Its products include Ximino, Targadox, Exelderm, Ceracade, and Luxamend. The company was founded in 2006 and is headquartered in Bay Harbor Islands, FL.
Market Cap
1 Year High
$26.69
Volume
1 Year Low
$18.96
Price to Earnings Ratio
Open
$21.41
Dividend Rate
$2.54
High
$21.91
Dividend Yield
11.80%
Low
$21.01

Community

People who own or watch FBIOP stock

FBIOP Stock News

FBIOP stock rating

What analysts recommend for FBIOP stock, on a scale from 1 (buy) to 5 (sell).
Buy
Sell

FBIOP price target

What analysts think FBIOP will be worth
Low $0
High $26.69
Current $21.52
Target $0

Buy FBIOP Stock

FBIOP
See FBIOP stock price and Buy/Sell Fortress Biotech Inc 9.375 % Cum Conv Perp Red Pfd Registered Shs Series A with any amount of money. Discuss news and analyst's price prediction with the investor community. Enter your cell phone number to get started.

Community

People who own or watch FBIOP stock
  • amydanielleh avatar
  • Lanell avatar
  • ORTIZFAM avatar
  • Faithassurance avatar
  • highrev avatar
Check the background of this firm on FINRA’s BrokerCheck.

© Copyright 2022 Public Holdings, Inc. All Rights Reserved.

Securities are offered to self-directed customers by Open to the Public Investing, Inc. (“Open to the Public Investing”), a registered broker-dealer and member of FINRA & SIPC. Additional information about your broker can be found by clicking here. Open to Public Investing is a wholly-owned subsidiary of Public Holdings Inc. (“Public Holdings”). This is not an offer, solicitation of an offer or advice to buy or sell securities, or open a brokerage account in any jurisdiction where Open to the Public Investing is not registered. Securities products offered by Open to the Public Investing are not FDIC insured.

Cryptocurrency trading is provided by Apex Crypto LLC (“Apex Crypto”). Apex Crypto is not a registered broker-dealer or FINRA member and is not affiliated with Public Holdings or any of its subsidiaries. Cryptocurrencies are not securities and your cryptocurrency holdings are not FDIC or SIPC insured. Crypto trading involves a substantial risk of loss as there is significant volatility in the price of cryptocurrencies.

Commission-free trading of stocks and ETFs refers to $0 commissions for Open to the Public Investing self-directed individual cash brokerage accounts that trade the U.S. listed securities electronically. Keep in mind, that other fees such as regulatory fees, Premium subscription fees, wire transfer fees, and paper statement fees may apply to your brokerage account. Please see Open to the Public Investing’s Fee Schedule to learn more.

All investments involve the risk of loss and the past performance of a security or a financial product does not guarantee future results or returns.